戻る Agenda
Regulation and Innovation: Driving the Co-development of Therapeutic Drug and Companion Diagnostics for Precision Medicine and Optimizing the Clinical Trial Design
Session Chair(s)
Jianqing Chang, DrMed
Vice President, Drug Regulatory Policy
Tigermed Consulting Ltd., China
This session will discuss the approach for simultaneous CTA submission, trial conduction, NDA submission and approval so as to speed up the simultaneous access to the innovative treatment.